NTRK1 and psoriasis: Since NGF is known to increase cutaneous innervation in AD models and might contribute to the development of chronic pruritus, NGF and its receptor TrkA could be targets for future treatment of pruritus and allergic inflammation in pruritic diseases like AD or psoriasis.